Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,333 | 10,004 | 12,052 | 10,792 | 12,362 |
| Receivables | 228 | 217 | 431 | 643 | 287 |
| TOTAL | $10,780 | $10,418 | $12,718 | $11,513 | $12,761 |
| Non-Current Assets | |||||
| Intangibles | 1,902 | 1,927 | 1,952 | 1,978 | 2,003 |
| Other Non-Current Assets | 39 | 40 | 41 | 40 | 41 |
| TOTAL | $1,941 | $1,967 | $1,993 | $2,018 | $2,044 |
| Total Assets | $12,721 | $12,385 | $14,710 | $13,531 | $14,805 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,910 | 2,188 | 756 | 1,079 | 673 |
| TOTAL | $3,910 | $2,188 | $756 | $1,079 | $673 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,910 | $2,188 | $756 | $1,079 | $673 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,641 | 8,892 | 8,348 | 8,334 | 7,038 |
| Common Shares | 62,416 | 58,933 | 57,900 | 54,515 | 54,271 |
| Retained earnings | -77,896 | -72,451 | -68,196 | -65,911 | -63,645 |
| Other shareholders' equity | -159 | -186 | -171 | -166 | -123 |
| TOTAL | $8,811 | $10,197 | $13,954 | $12,452 | $14,132 |
| Total Liabilities And Equity | $12,721 | $12,385 | $14,711 | $13,531 | $14,805 |